UNLIMITED TURBO LONG - TANDEM DIABETES CARE Share Price

Certificat

DE000PC9XY29

Market Closed - Boerse Frankfurt Warrants 01:20:34 03/07/2024 am IST
0.26 EUR -18.75% Intraday chart for UNLIMITED TURBO LONG - TANDEM DIABETES CARE
Current month-36.11%
1 month-83.45%
Date Price Change
02/24/02 0.23 -28.12%
01/24/01 0.32 -11.11%
28/24/28 0.36 -7.69%
27/24/27 0.39 0.00%
26/24/26 0.39 +11.43%

Real-time Boerse Frankfurt Warrants

Last update July 03, 2024 at 01:20 am IST

More quotes

Static data

Product typeKnock-Out sin Stop Loss
Buy / SellCALL
Underlying TANDEM DIABETES CARE, INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC9XY2
ISINDE000PC9XY29
Date issued 16/05/2024
Strike 38.47 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.65
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 1.59
Lowest since issue 0.2
Spread 0.02
Spread %6.90%

Company Profile

Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.
Sector
-
More about the company

Ratings for Tandem Diabetes Care, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Tandem Diabetes Care, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
39.15 USD
Average target price
49.93 USD
Spread / Average Target
+27.54%
Consensus